(Q53287201)

English

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.

scientific article published in April 2007

Statements

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit